Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis | Zendy

Carlos Rodríguez-Escaja | Zendy; C.A. Navascués | Zendy; M.L. González-Diéguez | Zendy; Valle Cadahía | Zendy; Marı́a Varela | Zendy; Miguel Ángel de Jorge Turrión | Zendy; Andrés CastañoGarcía | Zendy; Manuel Rodríguez | Zendy

Open Access

Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis

Author(s) -

Carlos Rodríguez-Escaja,

C.A. Navascués,

M.L. González-Diéguez,

Valle Cadahía,

Marı́a Varela,

Miguel Ángel de Jorge Turrión,

Andrés CastañoGarcía,

Manuel Rodríguez

Publication year - 2020

Publication title -

revista española de enfermedades digestivas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.331

H-Index - 38

eISSN - 2340-4167

pISSN - 1130-0108

DOI - 10.17235/reed.2020.6953/2020

Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , diabetes mellitus , gastroenterology , hepatitis c virus , alcoholic liver disease , alcoholic hepatitis , virus , virology , endocrinology

diabetes has been reported as a risk factor for hepatocellular carcinoma (HCC) in population-based studies but there are controversial data in patients with cirrhosis. Metformin could have a protective role in HCC development. The aim of this study was to determine the influence of diabetes on the risk of developing HCC in patients with alcohol- and hepatitis C virus (HCV)-related cirrhosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research